ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novo buys Ziylo for glucose-responsive insulin platform
fiercebiotech
August 20, 2018Novo Nordisk has?bought?Ziylo to fuel its work on next-generation insulins. The takeover gives Novo control of a platform that could support development of insulins that respond to glucose.
Pharma Sources Insight January 2025
